CRDQ

Québec, Quebec G1V 4X7

0 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2) — Completed